• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

舒敏保湿修复霜联合地奈德治疗儿童特应性皮炎的临床疗效研究

Study on the clinical efficacy of soothing moisturizing repairing cream combined with desonide in the treatment of atopic dermatitis in children.

作者信息

Zhang Yuping, Chen Yueqing, Li Chen

机构信息

Department of Dermatology, Zhongshan City People's Hospital, Zhongshan, Guangdong, China.

Guangdong Medical University, Zhanjiang, Guangdong, China.

出版信息

Medicine (Baltimore). 2025 Jan 17;104(3):e41277. doi: 10.1097/MD.0000000000041277.

DOI:10.1097/MD.0000000000041277
PMID:39833071
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11749664/
Abstract

This study evaluates the efficacy and safety of soothing moisturizing repairing cream combined with desonide in the treatment of atopic dermatitis (AD) in children in the real world. A total of 37 children with AD were randomly divided into experimental (17) and control (20) groups. For the experimental group, treated with moisturizing cream combined with desonide cream, the maintenance period was with moisturizer alone. For the control group, treated solely with desonide, the maintenance period was with nothing. Clinical assessments were made before and 1, 2, and 4 weeks after treatment. Efficacy indicators are compared between the 2 groups, and the relieving effect of moisturizer on the maintenance period of AD in children is observed. Adverse reactions are also recorded. After 4 weeks of treatment, the cure rate and effectiveness rate in the experimental group were 52.9% and 100%, respectively, compared to 0% and 60% in the control group; the estimated median maintenance time was 48 days for the control group and 73 days for the experimental group. The incidence of adverse reactions shows no statistical significance. The combination of moisturizing cream and desonide in the treatment of AD in children is highly effective and safe. It is worth promoting for clinical application due to its significant therapeutic effects and high safety profile.

摘要

本研究在现实世界中评估舒缓保湿修复霜联合地奈德治疗儿童特应性皮炎(AD)的疗效和安全性。共37例AD患儿被随机分为试验组(17例)和对照组(20例)。试验组采用保湿霜联合地奈德乳膏治疗,维持期仅使用保湿剂。对照组仅用地奈德治疗,维持期不使用任何药物。在治疗前以及治疗后1、2和4周进行临床评估。比较两组的疗效指标,观察保湿剂对儿童AD维持期的缓解作用。同时记录不良反应。治疗4周后,试验组的治愈率和有效率分别为52.9%和100%,而对照组分别为0%和60%;对照组的估计中位维持时间为48天,试验组为73天。不良反应发生率无统计学意义。保湿霜与地奈德联合治疗儿童AD高效且安全。因其显著的治疗效果和高安全性,值得在临床应用中推广。

相似文献

1
Study on the clinical efficacy of soothing moisturizing repairing cream combined with desonide in the treatment of atopic dermatitis in children.舒敏保湿修复霜联合地奈德治疗儿童特应性皮炎的临床疗效研究
Medicine (Baltimore). 2025 Jan 17;104(3):e41277. doi: 10.1097/MD.0000000000041277.
2
Effectiveness of a nurse-led one-to-one education programme in addition to standard care in children with atopic dermatitis: a multicentre randomized control trial.在常规护理基础上增加护士主导的一对一教育方案对特应性皮炎患儿的疗效:一项多中心随机对照试验。
Br J Dermatol. 2024 Jul 16;191(2):177-186. doi: 10.1093/bjd/ljae111.
3
Topical anti-inflammatory treatments for eczema: network meta-analysis.外用抗炎治疗湿疹:网状荟萃分析。
Cochrane Database Syst Rev. 2024 Aug 6;8(8):CD015064. doi: 10.1002/14651858.CD015064.pub2.
4
Phototherapy for atopic eczema.光疗治疗特应性皮炎。
Cochrane Database Syst Rev. 2021 Oct 28;10(10):CD013870. doi: 10.1002/14651858.CD013870.pub2.
5
Strategies for using topical corticosteroids in children and adults with eczema.湿疹患儿和成人中局部皮质类固醇的使用策略。
Cochrane Database Syst Rev. 2022 Mar 11;3(3):CD013356. doi: 10.1002/14651858.CD013356.pub2.
6
The effectiveness and cost-effectiveness of pimecrolimus and tacrolimus for atopic eczema: a systematic review and economic evaluation.吡美莫司和他克莫司治疗特应性皮炎的有效性和成本效益:一项系统评价与经济评估
Health Technol Assess. 2005 Jul;9(29):iii, xi-xiii,1-230. doi: 10.3310/hta9290.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
8
Dexrazoxane for preventing or reducing cardiotoxicity in adults and children with cancer receiving anthracyclines.右雷佐生预防或减少接受蒽环类抗生素治疗的癌症成人和儿童的心脏毒性。
Cochrane Database Syst Rev. 2022 Sep 27;9(9):CD014638. doi: 10.1002/14651858.CD014638.pub2.
9
Atypical antipsychotics for disruptive behaviour disorders in children and youths.用于治疗儿童和青少年破坏性行为障碍的非典型抗精神病药物。
Cochrane Database Syst Rev. 2017 Aug 9;8(8):CD008559. doi: 10.1002/14651858.CD008559.pub3.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.

本文引用的文献

1
Long-term effectiveness and safety of upadacitinib for Japanese patients with moderate-to-severe atopic dermatitis: a real-world clinical study.乌帕替尼治疗中重度特应性皮炎日本患者的长期疗效和安全性:一项真实世界临床研究。
J Dermatolog Treat. 2024 Dec;35(1):2344591. doi: 10.1080/09546634.2024.2344591. Epub 2024 Apr 23.
2
Effectiveness and Safety of Upadacitinib in Combination with Topical Corticosteroids in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis.乌帕替尼联合外用糖皮质激素治疗中度至重度特应性皮炎青少年患者的有效性和安全性。
Clin Cosmet Investig Dermatol. 2023 Nov 7;16:3201-3212. doi: 10.2147/CCID.S439053. eCollection 2023.
3
European guideline (EuroGuiDerm) on atopic eczema - part II: non-systemic treatments and treatment recommendations for special AE patient populations.
欧洲特应性皮炎指南(EuroGuiDerm)- 第二部分:非系统性治疗和特殊特应性皮炎患者人群的治疗建议。
J Eur Acad Dermatol Venereol. 2022 Nov;36(11):1904-1926. doi: 10.1111/jdv.18429. Epub 2022 Sep 3.
4
Skin Barrier Abnormalities and Immune Dysfunction in Atopic Dermatitis.特应性皮炎的皮肤屏障异常和免疫功能障碍。
Int J Mol Sci. 2020 Apr 20;21(8):2867. doi: 10.3390/ijms21082867.
5
Corrigendum: Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I.勘误:基于共识的欧洲成人及儿童特应性皮炎治疗指南:第一部分。
J Eur Acad Dermatol Venereol. 2019 Jul;33(7):1436. doi: 10.1111/jdv.15719.
6
Phenotypic analysis of atopic dermatitis in children aged 1-12 months: elaboration of novel diagnostic criteria for infants in China and estimation of prevalence.1-12 月龄婴儿特应性皮炎表型分析:中国婴儿新诊断标准的制定及患病率评估。
J Eur Acad Dermatol Venereol. 2019 Aug;33(8):1569-1576. doi: 10.1111/jdv.15618. Epub 2019 May 17.
7
Evidence-based treatment of atopic dermatitis with topical moisturizers.基于循证医学的外用保湿剂治疗特应性皮炎
G Ital Dermatol Venereol. 2018 Jun;153(3):396-402. doi: 10.23736/S0392-0488.18.05898-4. Epub 2018 Jan 24.
8
Prevalence of Atopic Dermatitis in Chinese Children aged 1-7 ys.中国 1-7 岁儿童特应性皮炎的患病率。
Sci Rep. 2016 Jul 19;6:29751. doi: 10.1038/srep29751.
9
Effective treatment for sensitive skin: 4-t-butylcyclohexanol and licochalcone A.敏感肌肤的有效治疗方法:4-叔丁基环己醇和光甘草定A。
J Eur Acad Dermatol Venereol. 2016 Feb;30 Suppl 1:9-17. doi: 10.1111/jdv.13529.
10
The Genetics and Epigenetics of Atopic Dermatitis-Filaggrin and Other Polymorphisms.特应性皮炎的遗传学与表观遗传学——丝聚合蛋白及其他多态性
Clin Rev Allergy Immunol. 2016 Dec;51(3):315-328. doi: 10.1007/s12016-015-8508-5.